BlueCross BlueShield of Tennessee Medical Policy Manual

Virtual Colonoscopy (Computed Tomography Colonography)

DESCRIPTION

Virtual colonoscopy (i.e., CT colonography) is an imaging procedure involving the use of spiral (helical) CT scanning and computers to produce a three-dimensional colonoscopic visualization of the colon and rectum. Some studies have suggested that this technique may be an attractive alternative to existing screening tests for colorectal cancer, since it is considered relatively safe and minimally invasive.

The procedure generally involves four steps: bowel cleansing, pneumocolon (air enema), spiral CT scanning and computer processing of the spiral CT images. With a virtual colonoscopy it is not possible to remove polyps or perform a biopsy. If a potential problem is found an additional procedure such as a conventional colonoscopy is needed.

POLICY

MEDICAL APPROPRIATENESS

IMPORTANT REMINDER

We develop Medical Policies to provide guidance to Members and Providers. This Medical Policy relates only to the services or supplies described in it. The existence of a Medical Policy is not an authorization, certification, explanation of benefits or a contract for the service (or supply) that is referenced in the Medical Policy. For a determination of the benefits that a Member is entitled to receive under his or her health plan, the Member's health plan must be reviewed. If there is a conflict between the Medical Policy and a health plan, the express terms of the health plan will govern.

ADDITIONAL INFORMATION

Intravenous contrast is not usually used for routine computed tomography colonography (CTC), however the American College of Radiology (ACR) states that “a contrasted diagnostic computed tomography colonography (CTC) study may be useful in some patients after incomplete endoscopy to characterize indeterminate colonic masses or to better visualize colonic segments with excess fluid.”

A large comparative study has shown that computed tomography colonography (CTC) produced similar rates of detection for advanced neoplasia as conventional colonoscopy and is an effective method for colorectal screening. Although these results support the efficacy and safety of CTC for colorectal cancer screening, there are only limited follow-up data available so far for patients who underwent CTC and opted to have follow-up surveillance screening for polyps 6 to 9 mm in size. In addition, specific criteria needs to be developed to ensure that physicians are adequately trained and quality metrics for programs are in place.

Published evidence of well-designed studies in peer review journals is insufficient to determine whether the use of virtual colonoscopy (Computed Tomography Colonography) would improve population screening. The availability of literature consists of survey studies, patient satisfaction studies, and focus group studies. It is unclear how such studies provide a sufficient base of evidence to demonstrate that population adherence to colon cancer screening would improve.

SOURCES

American College of Radiology. (2009). 2010 CPT® code update. Retrieved August 17, 2010 from http://www.acr.org/Hidden/Economics/FeaturedCategories/Pubs/coding_source/archives/SeptOct09/2010CPTCodeUpdate.aspx.

Barish, M. A., Zalis, M. E., & Harris, G. J. (2006, June). CT colonography: Current status and economics. Retrieved August 17, 2010 from http://www.imagingeconomics.com/issues/articles/2006-06_03.asp.

BlueCross BlueShield Association. Medical Policy Reference Manual. (8:2009). Virtual colonoscopy/CT colonography (6.01.32). Retrieved December 28, 2010 from BlueWeb. (23 articles and/or guidelines reviewed)

Kim, D. H., Pickhardt, P. J., Taylor, A. J., Leung, W. K., Winter, T. C., Hinshaw, J. L., et al. (2007). CT colonography versus colonoscopy for the detection of advanced neoplasia. The New England Journal of Medicine, 357 (14), 1403-1412.

Levin, B., Lieberman, D. A., McFarland, B. Smith, R. A., Brooks, D., Andrews, K. S., et al. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA, 58 (3), 130-160.

ORIGINAL EFFECTIVE DATE:  8/1/2001   

MOST RECENT REVIEW DATE:  1/28/2011  

ID_MS; BA

Policies included in the Medical Policy Manual are not intended to certify coverage availability. They are medical determinations about a particular technology, service, drug, etc. While a policy or technology may be medically necessary, it could be excluded in a member's benefit plan. Please check with the appropriate claims department to determine if the service in question is a covered service under a particular benefit plan. Use of the Medical Policy Manual is not intended to replace independent medical judgment for treatment of individuals. The content on this Web site is not intended to be a substitute for professional medical advice in any way. Always seek the advice of your physician or other qualified health care provider if you have questions regarding a medical condition or treatment.

This document has been classified as public information.